These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 31214762)
1. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Madsen ML; Due H; Ejskjær N; Jensen P; Madsen J; Dybkær K Cancer Chemother Pharmacol; 2019 Sep; 84(3):471-485. PubMed ID: 31214762 [TBL] [Abstract][Full Text] [Related]
2. Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term Outcome. Egan-Sherry D; Bhuta R; Cole PD; Gennarini LM; Kahn JM; Sulis ML; DeNardo BD; Welch JJG J Pediatr Hematol Oncol; 2021 Oct; 43(7):e997-e999. PubMed ID: 34001785 [TBL] [Abstract][Full Text] [Related]
3. Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma. Pana ZD; Roilides E Pediatr Blood Cancer; 2011 Jul; 57(1):30-5. PubMed ID: 21265011 [TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced peripheral neuropathy: A mini-review. Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366 [TBL] [Abstract][Full Text] [Related]
5. Genetic factors influencing the development of vincristine-induced neurotoxicity. Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553 [No Abstract] [Full Text] [Related]
6. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies. Dudeja S; Gupta S; Sharma S; Jain A; Sharma S; Jain P; Aneja S; Chandra J Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565 [TBL] [Abstract][Full Text] [Related]
7. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029 [TBL] [Abstract][Full Text] [Related]
8. Severe vincristine neurotoxicity with concomitant use of itraconazole. Ariffin H; Omar KZ; Ang EL; Shekhar K J Paediatr Child Health; 2003 Nov; 39(8):638-9. PubMed ID: 14629538 [No Abstract] [Full Text] [Related]
9. Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population. Kayilioğlu H; Kocak U; Kan Karaer D; Percin EF; Sal E; Tekkesin F; Isik M; Oner N; Belen FB; Yilmaz Keskin E; Okur A; Albayrak M; Kaya Z; Pinarli FG; Yenicesu I; Karadeniz C; Oguz A; Gursel T J Pediatr Hematol Oncol; 2017 Aug; 39(6):458-462. PubMed ID: 28697165 [TBL] [Abstract][Full Text] [Related]
10. Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children's Oncology Group. Smolik S; Arland L; Hensley MA; Schissel D; Shepperd B; Thomas K; Rodgers C J Pediatr Oncol Nurs; 2018; 35(4):267-275. PubMed ID: 29566596 [TBL] [Abstract][Full Text] [Related]
11. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review. van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies. Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438 [TBL] [Abstract][Full Text] [Related]
14. The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity. Barzegar-Fallah A; Alimoradi H; Mehrzadi S; Barzegar-Fallah N; Zendedel A; Abbasi A; Dehpour AR Neurotoxicology; 2014 Mar; 41():1-8. PubMed ID: 24374478 [TBL] [Abstract][Full Text] [Related]
15. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Sands S; Ladas EJ; Kelly KM; Weiner M; Lin M; Ndao DH; Dave A; Vahdat LT; Bender JG Support Care Cancer; 2017 Mar; 25(3):701-708. PubMed ID: 27830395 [TBL] [Abstract][Full Text] [Related]
16. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases. Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626 [TBL] [Abstract][Full Text] [Related]
17. Vincristine-induced fatal neuropathy in non-Hodgkin's lymphoma. Tarlaci S Neurotoxicology; 2008 Jul; 29(4):748-9. PubMed ID: 18754106 [TBL] [Abstract][Full Text] [Related]
18. Experience with vincristine--associated neurotoxicity. Othieno-Abinya NA; Nyabola LO East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264 [TBL] [Abstract][Full Text] [Related]
19. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia. Lopez-Lopez E; Gutierrez-Camino A; Astigarraga I; Navajas A; Echebarria-Barona A; Garcia-Miguel P; Garcia de Andoin N; Lobo C; Guerra-Merino I; Martin-Guerrero I; Garcia-Orad A Pharmacogenomics; 2016 May; 17(7):731-41. PubMed ID: 27180762 [TBL] [Abstract][Full Text] [Related]
20. Ameliorative potential of ferulic acid in vincristine-induced painful neuropathy in rats: An evidence of behavioral and biochemical examination. Vashistha B; Sharma A; Jain V Nutr Neurosci; 2017 Jan; 20(1):60-70. PubMed ID: 25494651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]